Cure pharmaceutical to present at h.c. wainwright 2021 psychedelics in psychiatry and beyond virtual conference

Oxnard, calif.--(business wire)--cure pharmaceutical holding corp. (otc: curr), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its chief business officer jonathan berlent will participate in a virtual presentation at the h.c. wainwright psychedelics in psychiatry and beyond virtual conference on thursday, june 17. "the potential therapeutic benefits of psychedelics to treat m
CURR Ratings Summary
CURR Quant Ranking